7*24 Hotline：
Guilin Sanjin Pharmaceutical Co., Ltd. (002275)
Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin group, which is mainly engaged in the R & D and production of Chinese patent medicine and natural medicine. It is one of the earliest manufacturers of modern Chinese medicine preparations in China. Since 1985, Guilin Sanjin has been adhering to reform and innovation, relying on scientific and technological progress and scientific management, transforming from an unknown small traditional Chinese medicine factory into a national well-known modern Chinese medicine enterprise, ranking among the top 50 in Chinese traditional medicine industry. The enterprise has won the national enterprise management outstanding contribution award, the national "May 1" labor award, the national excellent enterprise of Ideological and political work, the national civilized unit, the national excellent enterprise of traditional Chinese medicine industry and other honors.
As a well-known high-tech enterprise inside and outside the zone, Sanjin has established a state recognized enterprise technology center, postdoctoral research workstation, Guangxi Academy of traditional Chinese medicine industrialization engineering and other innovation platforms. Over the years, it has been committed to promoting and implementing the modernization plan of traditional Chinese medicine industry, and actively cultivating and improving the independent innovation ability of enterprises. The company's characteristic Chinese medicine new drugs are developed by the enterprise technology center. At present, Sanjin has more than 200 registered varieties and 13 pharmaceutical dosage forms, and has 42 unique varieties independently developed, such as Guilin Watermelon Frost, watermelon frost throat tablet, Sanjin tablet, Naomaitai Capsule, etc. After years of efforts, Sanjin has formed a strong professional and market advantage in throat, oral and urinary medicine. Sanjin watermelon cream series and Sanjin tablets, the representative products, have been in the forefront of similar Chinese patent medicines in China for many years.
In July 2009, with a new look of high growth and high efficiency, Guilin Sanjin successfully entered the capital market and ushered in a new stage of rapid development. In recent years, in order to actively respond to the call of Guilin municipal Party committee and government to "develop westward and rebuild a new Guilin", and to solve the contradiction between the scattered production bases and storage facilities of enterprises and the rapid development of enterprises, Sanjin has launched the construction of "Sanjin modern Chinese medicine industrialization technology transformation project". At present, the first phase of the project has been officially put into operation and the overall relocation of the main production lines has been realized.
In the face of the future, Sanjin will adhere to the enterprise mission of "innovation promotes the progress of medicine" and the enterprise spirit of "dare to be the first", implement the development strategy of "one body, two wings" with traditional Chinese medicine as the main body and committed to the development of biopharmaceutical and big health industry, regard quality and reputation as the first life of the enterprise, break through innovation, continuously enhance the competitive strength of Sanjin, forge ahead, and serve the country with development and reputation Return to investors, to build China's leading pharmaceutical manufacturing group as the goal, promote the modernization and internationalization of traditional Chinese medicine industry!
oil wellhead